Literature DB >> 22711972

Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of Covariates.

Changfu Xiao1, Anastasia Ivanova.   

Abstract

We consider a problem of estimating the minimum effective and peak doses in the presence of covariates. We propose a sequential strategy for subject assignment that includes an adaptive randomization component to balance the allocation to placebo and active doses with respect to covariates. We conclude that either adjusting for covariates in the model or balancing allocation with respect to covariates is required to avoid bias in the target dose estimation. We also compute optimal allocation to estimate the minimum effective and peak doses in discrete dose space using isotonic regression.

Entities:  

Year:  2012        PMID: 22711972      PMCID: PMC3375738          DOI: 10.1016/j.jspi.2012.01.024

Source DB:  PubMed          Journal:  J Stat Plan Inference        ISSN: 0378-3758            Impact factor:   1.111


  17 in total

1.  Designs for single- or multiple-agent phase I trials.

Authors:  Mark R Conaway; Stephanie Dunbar; Shyamal D Peddada
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

2.  Combining multiple comparisons and modeling techniques in dose-response studies.

Authors:  F Bretz; J C Pinheiro; M Branson
Journal:  Biometrics       Date:  2005-09       Impact factor: 2.571

3.  Minimization: a new method of assigning patients to treatment and control groups.

Authors:  D R Taves
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

4.  Bivariate isotonic design for dose-finding with ordered groups.

Authors:  Anastasia Ivanova; Kai Wang
Journal:  Stat Med       Date:  2006-06-30       Impact factor: 2.373

5.  Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.

Authors:  Yisheng Li; B Nebiyou Bekele; Yuan Ji; John D Cook
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

6.  Patient-specific dose finding based on bivariate outcomes and covariates.

Authors:  Peter F Thall; Hoang Q Nguyen; Elihu H Estey
Journal:  Biometrics       Date:  2008-03-19       Impact factor: 2.571

7.  Cancer phase I clinical trials: efficient dose escalation with overdose control.

Authors:  J Babb; A Rogatko; S Zacks
Journal:  Stat Med       Date:  1998-05-30       Impact factor: 2.373

8.  Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control.

Authors:  Ying Kuen Cheung
Journal:  Biometrics       Date:  2007-10-19       Impact factor: 2.571

9.  Continual reassessment method for ordered groups.

Authors:  John O'Quigley; Xavier Paoletti
Journal:  Biometrics       Date:  2003-06       Impact factor: 2.571

10.  Monitoring late-onset toxicities in phase I trials using predicted risks.

Authors:  B Nebiyou Bekele; Yuan Ji; Yu Shen; Peter F Thall
Journal:  Biostatistics       Date:  2007-12-14       Impact factor: 5.899

View more
  1 in total

1.  Dose finding when the target dose is on a plateau of a dose-response curve: comparison of fully sequential designs.

Authors:  Anastasia Ivanova; Changfu Xiao
Journal:  Pharm Stat       Date:  2013-07-26       Impact factor: 1.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.